The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by European Medicines Agency (EMA) and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law. In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other national societies active in human pharmacology are invited to apply to become members. Institutions, pharma or service provider companies can apply for associate membership.
08.12.2023: Webinar – Scientific Christmas Lecture ...
Scientific Christmas Lecture Webinar on 08 December 2023 at 16:00-17:30 CET Organiser: Jan De Hoon SAVE THE DATE! ...15.09.2023: Webinar – Patient/Participant engagement in expl ...
Patient/Participant engagement in exploratory clinical development Webinar on 15 September 2023 at 16:00-17:30 CET Organiser: Ingrid Klingmann Register Here ...[DATE TBA] Webinar – What do you need when going from animal ...
A joint regulatory and market access perspective on planning ATMP development New date to be announced Organiser: Izaak Den Daas Agenda: Intro / Overview on opportunities and challenges with ATMPs… Read More ...
Upcoming events
About us
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development. You can find our Mission Statement here.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a ‘voice’ in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Read more about us here >
